Senior Cancer Research Fellowship
November 2024
Mechanisms, consequences and clinical translation of MHC-I and MHC-II dysregulation in colorectal and endometrial (pre)cancer
Explore the Senior Cancer Research Fellowship
Advanced Clinician Scientist Fellowship
May 2025
Towards next-generation chimeric antigen receptor (CAR) therapies for acute leukaemia: a mechanistic dissection of therapeutic efficacy
Dr Sara Ghorashian
The UCL Great Ormond Street Institute of Child Health
(with support from Great Ormond Street Hospital Charity)
November 2024
Spatial prostate assessment and the circulating environment - discovering the lethal clone (SPACE-X)
Dr Alastair Lamb
Queen Mary University of London
Explore the Advanced Clinician Scientist Fellowship
Career Development Fellowship
May 2025
Dedifferentiation and cancer: dissecting the molecular link between tissue injury and tumour initiation
Dr Miguel Bernabé-Rubio
University College London
Improving access to lung cancer early detection for individuals with severe mental illness and intellectual disability: reducing health inequity
November 2024
Identifying strategies for preventing/reversing chemoresistance in ovarian cancer
Deciphering the dynamics of melanoma plasticity
Explore the Career Development Fellowship
Career Establishment Award
May 2025
Exploiting anti-plasticity strategies to interfere with adaptive evolution in childhood neuroblastoma
Dr Alejandra Bruna
Institute of Cancer Research
November 2024
Identifying, understanding and addressing inequalities in cancer treatment
Explore the Career Establishment Award
Clinician Scientist Fellowship
November 2024
Chemotherapeutic opportunities of metabolic heterogeneity in oesophageal adenocarcinoma (COMET)
Dr Stefan Antonowicz
Imperial College London
Funded by Cancer Research UK in partnership with Rosetrees Trust
Interrogating and targeting mechanisms by which cancer-associated fibroblasts limit radiotherapy responses in bladder cancer
Dr Anna Wilkins
Institute of Cancer Research
Explore the Clinician Scientist Fellowship
Pre-doctoral Research Bursary
May 2025
The role and mechanism of highly variable genetic factors in cancer risk and prevention
Unravelling tumour-host metabolic interactions that underpin the efficacy of metformin in high-volume metastatic hormone sensitive prostate cancer
Exploring the clonal landscape of oral potentially malignant disorders
Dr Grigorios Thermos
University of Liverpool
(co-funded by Cancer Research UK and the Pathological Society)
Evaluation of pre-operative ultra-high field magnetic resonance imaging for planning skull base tumour resection
November 2024
Proposal for pre-treatment CT/MRI derived radiomics and machine learning (ML) models for predicting treatment and immune-response in patients undergoing image-guided ablation and histotripsy for small renal masses and liver tumours: a proof-of-concept study
Developing new cell models for brain tumours which use the alternative lengthening of telomeres pathway
Socio-demographic inequalities of access to novel genomic testing and therapeutics in solid tumours in the UK
Exploring the potential of polymerase theta inhibition as a strategy for the radiosensitisation of oesophageal adenocarcinoma
Explore the Pre-doctoral Research Bursary
Postdoctoral Research Bursary
May 2025
Distinct clonal alloimmune responses drive human graft versus leukaemia effect and graft versus host disease
November 2024
Characterisation of the NK cell response to HIPEC in high-grade serous ovarian cancer
Explore the Postdoctoral Research Bursary
Clinical Trial Fellowship
November 2024
Transforming oncology trials: using big data for better outcomes
Dr Grisma Patel
University College London
Explore the Clinical Trial Fellowship
Bridge to Academic Leadership
May 2025
Identifying novel targets for proximal colon cancer prevention and early detection
Advanced causal modelling to improve understanding of late effects of radiotherapy in children and young adults
Gaining traction in glioblastoma therapy: targetable mechanisms of force generation
Refining HER2 diagnostics for an ultra-sensitive, objective assessment to guide therapy, inform resistance and monitor dynamic changes
Targeting translation quality control machinery to enhance the efficiency of genotoxic drugs in colon cancer
Dr Susanta Chatterjee
Queen's University Belfast
Investigating cancer induced haematopoietic dysfunction: impact, mechanism and therapeutic potential
Dr Christopher Mapperley
Institute of Cancer Research
Explore the Bridge to Academic Leadership programme
